Jove
Visualize
联系我们

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Surgical outcomes and risk factors for complications after tracheal resection in benign tracheal stenosis: A 15-year single-center experience.

Turk gogus kalp damar cerrahisi dergisi·2026
Same author

Comparison of subxiphoid and lateral intercostal approach in anterior mediastinal pathologies.

Turk gogus kalp damar cerrahisi dergisi·2026
Same author

Segmentectomy or Lobectomy in T1N0M0 Non-Small Cell Lung Carcinomas: The Prognostic Role of Histology and Vascular Invasion.

Updates in surgery·2026
Same author

Preconditioning Surgery for Pneumonectomy: A Case Report of Contralateral Lung Bullectomy.

Journal of chest surgery·2025
Same author

The predictive significance of inflammatory parameters for postoperative complications in patients undergoing videothoracoscopic pulmonary resection for lung cancer.

Updates in surgery·2025
Same author

Survival analysis between single-factor and multi-factor groups in Stage T3N0M0 non-small cell lung cancer.

Turk gogus kalp damar cerrahisi dergisi·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

633

在经过新辅助治疗后手术的肺癌患者的预后因素的比较.

Dilvin Ozkan1, Muhammet Sayan2, Sevki Mustafa Demiroz2

  • 1Milas State Hospital, Department of Thoracic Surgery, Mugla, Turkey.

Portuguese journal of cardiac thoracic and vascular surgery
|November 13, 2025
PubMed
概括

肺癌的新辅助治疗后的手术显示,当完全切除时,存活率有所改善. 影响结果的关键因素包括患者年龄,瘤大小和治疗反应.

关键词:
新辅助剂是一种新辅助剂.非小细胞肺癌的肺癌.肺切除 肺切除 肺切除 肺切除幸存率 幸存率 生存率

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

478
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K

相关实验视频

Last Updated: Jan 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

633
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

478
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K

科学领域:

  • 胸部外科手术 胸部外科手术
  • 手术瘤学手术瘤学
  • 肺部医学 肺部医学

背景情况:

  • 肺癌是全球癌症死亡的主要原因之一.
  • 手术切除是早期非小细胞肺癌 (NSCLC) 的首要治疗方法.
  • 术后的新辅助治疗是局部晚期NSCLC的一种策略.

研究的目的:

  • 为了评估NSCLC患者的生存结果,接受手术后的新辅助疗法.
  • 为了确定影响该患者队列生存的预后因素.

主要方法:

  • 在2012-2022年期间接受治疗的96名NSCLC患者的回顾性分析.
  • 收集关于人口统计,治疗,手术细节和组织病理学的数据.
  • 生存分析与预后因素相关,如年龄,瘤大小和切除状态.

主要成果:

  • 平均整体生存时间为41个月,5年生存率为42.4%.
  • 预后不佳的因素包括年龄>65,瘤进展,瘤直径>2.65厘米,不完整的切除和晚期TNM阶段.
  • 没有发现存活率与性别,组织病理学或手术方法之间的显著相关性.

结论:

  • 年龄,治疗后瘤直径,完全切除能力和瘤进展是局部发达NSCLC手术规划的关键考虑因素.
  • 根据这些因素优化手术策略可能会改善患者的治疗结果.